Your browser doesn't support javascript.
Online Hydrophilic Interaction Chromatography (HILIC) Enhanced Top-Down Mass Spectrometry Characterization of the SARS-CoV-2 Spike Receptor-Binding Domain.
Wilson, Jesse W; Bilbao, Aivett; Wang, Juan; Liao, Yen-Chen; Velickovic, Dusan; Wojcik, Roza; Passamonti, Marta; Zhao, Rui; Gargano, Andrea F G; Gerbasi, Vincent R; Pas A-Tolic, Ljiljana; Baker, Scott E; Zhou, Mowei.
  • Wilson JW; Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, 3335 Innovation Boulevard, Richland, Washington 99354, United States.
  • Bilbao A; Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, 3335 Innovation Boulevard, Richland, Washington 99354, United States.
  • Wang J; Biological Sciences Division, Pacific Northwest National Laboratories, 902 Battelle Boulevard, Richland, Washington 99354, United States.
  • Liao YC; Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, 3335 Innovation Boulevard, Richland, Washington 99354, United States.
  • Velickovic D; Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, 3335 Innovation Boulevard, Richland, Washington 99354, United States.
  • Wojcik R; National Security Directorate, Pacific Northwest National Laboratories, 902 Battelle Boulevard, Richland, Washington 99354, United States.
  • Passamonti M; Centre for Analytical Sciences Amsterdam, Amsterdam 1098 XH, The Netherlands.
  • Zhao R; Van't Hoff Institute for Molecular Sciences, University of Amsterdam, Amsterdam 1098 XH, The Netherlands.
  • Gargano AFG; Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, 3335 Innovation Boulevard, Richland, Washington 99354, United States.
  • Gerbasi VR; Centre for Analytical Sciences Amsterdam, Amsterdam 1098 XH, The Netherlands.
  • Pas A-Tolic L; Van't Hoff Institute for Molecular Sciences, University of Amsterdam, Amsterdam 1098 XH, The Netherlands.
  • Baker SE; Biological Sciences Division, Pacific Northwest National Laboratories, 902 Battelle Boulevard, Richland, Washington 99354, United States.
  • Zhou M; Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, 3335 Innovation Boulevard, Richland, Washington 99354, United States.
Anal Chem ; 94(15): 5909-5917, 2022 04 19.
Article in English | MEDLINE | ID: covidwho-1882715
ABSTRACT
SARS-CoV-2 cellular infection is mediated by the heavily glycosylated spike protein. Recombinant versions of the spike protein and the receptor-binding domain (RBD) are necessary for seropositivity assays and can potentially serve as vaccines against viral infection. RBD plays key roles in the spike protein's structure and function, and thus, comprehensive characterization of recombinant RBD is critically important for biopharmaceutical applications. Liquid chromatography coupled to mass spectrometry has been widely used to characterize post-translational modifications in proteins, including glycosylation. Most studies of RBDs were performed at the proteolytic peptide (bottom-up proteomics) or released glycan level because of the technical challenges in resolving highly heterogeneous glycans at the intact protein level. Herein, we evaluated several online separation techniques (1) C2 reverse-phase liquid chromatography (RPLC), (2) capillary zone electrophoresis (CZE), and (3) acrylamide-based monolithic hydrophilic interaction chromatography (HILIC) to separate intact recombinant RBDs with varying combinations of glycosylations (glycoforms) for top-down mass spectrometry (MS). Within the conditions we explored, the HILIC method was superior to RPLC and CZE at separating RBD glycoforms, which differ significantly in neutral glycan groups. In addition, our top-down analysis readily captured unexpected modifications (e.g., cysteinylation and N-terminal sequence variation) and low abundance, heavily glycosylated proteoforms that may be missed by using glycopeptide data alone. The HILIC top-down MS platform holds great potential in resolving heterogeneous glycoproteins for facile comparison of biosimilars in quality control applications.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Anal Chem Year: 2022 Document Type: Article Affiliation country: Acs.analchem.2c00139

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Anal Chem Year: 2022 Document Type: Article Affiliation country: Acs.analchem.2c00139